SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000904454-12-000381
Filing Date
2012-08-02
Accepted
2012-08-02 14:28:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D FOR DURATA THERAPEUTICS, INC. s13d_080212-durata.htm SC 13D 109680
  Complete submission text file 0000904454-12-000381.txt   111254
Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542 609-683-5656
Domain Partners VIII, L.P. (Filed by) CIK: 0001465144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86923 | Film No.: 121002978
SIC: 2834 Pharmaceutical Preparations